Skip to main content
BusinessResearch

Alphabet’s Isomorphic Labs raises $5B to accelerate drug discovery with AI

Source: SiliconANGLE (opens in a new tab) · Maria Deutscher

Intel Summary

Isomorphic Labs announced it has secured a $5 billion funding round led by Greenoaks and Sequoia Capital, with participation from parent company Alphabet via GV and CapitalG alongside additional investors. The funding is intended to accelerate the company's AI-driven drug discovery programs.

Why It Matters

A multi-billion-dollar round of this scale represents a significant concentration of capital into computational biology. The funding provides Isomorphic Labs with substantial runway to commercialize and scale its AI models for pharmaceutical research and drug design pipelines.

Organizations & Entities

Topics